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Background: The collagen chaperone HSP47 is implicated in recessive osteogenesis imperfecta (OI).
Results: In OI dachshunds, an HSP47(L326P) mutation affects the post-translational modification, secretion, and cross-linking
of collagen type I.
Conclusion: Impaired chaperone function, ER stress, and aberrant bone collagen cross-linking are implicated in the disease
mechanism.
Significance:Our findings are relevant for the diagnosis and pathological understanding of OI caused by an HSP47 defect.
Osteogenesis imperfecta (OI) is a heritable connective tissue
disease characterizedbybone fragility and increased risk of frac-
tures. Up to now, mutations in at least 18 genes have been asso-
ciated with dominant and recessive forms of OI that affect the
production or post-translational processing of procollagen or
alter bonehomeostasis.Among those,SERPINH1 encodingheat
shock protein 47 (HSP47), a chaperone exclusive for collagen
folding in the ER, was identified to cause a severe form of OI in
dachshunds (L326P) as well as in humans (one single case with a
L78P mutation). To elucidate the disease mechanism underly-
ing OI in the dog model, we applied a range of biochemical
assays to mutant and control skin fibroblasts as well as on bone
samples. These experiments revealed that type I collagen syn-
thesized by mutant cells had decreased electrophoretic mobil-
ity. Procollagen was retained intracellularly with concomitant
dilation of ER cisternae and activation of the ER stress response
markers GRP78 and phospho-eIF2, thus suggesting a defect in
procollagen processing. In linewith themigration shift detected
on SDS-PAGE of cell culture collagen, extracts of bone collagen
from the OI dog showed a similar mobility shift, and on tandem
mass spectrometry, the chains were post-translationally over-
modified. The bone collagen had a higher content of pyridino-
line than control dog bone. We conclude that the SERPINH1
mutation in this naturally occurring model of OI impairs how
HSP47 acts as a chaperone in the ER. This results in abnormal
post-translational modification and cross-linking of the bone
collagen.
Osteogenesis imperfecta (OI)2 or “brittle bone disease” is a het-
erogeneous heritable disorder of bone matrix formation and
homeostasis. Its cardinal manifestations are low bone mass
and reduced bone strength, leading to increased bone fragility
and deformity. Other common clinical findings include short
stature, progressive conductive hearing loss, and blue-gray
sclerae as well as brittle opalescent teeth (dentinogenesis
imperfecta).
In90%of individualswith the clinical diagnosis ofOI, dom-
inant mutations in the type I collagen coding genes COL1A1
(Online Mendelian Inheritance in Man (OMIM) 120150) and
COL1A2 (OMIM 120160) are responsible for the disorder (1).
Over the last 8 years, mutations in several noncollagenous
genes involved in the post-translational processing of procolla-
gen I, in osteoblast-specific signaling, or in gene regulation have
been characterized in either dominant or recessive forms of OI:
CRTAP (OMIM 605497), LEPRE1 (OMIM 610339), PPIB
(OMIM 123841), PLOD2 (OMIM 601865), FKBP10 (OMIM
607063), BMP1 (OMIM 112264), CREB3L1 (Entrez ID 90993),
IFITM5 (OMIM 614757), PLS3 (OMIM 300131), TMEM38B
(OMIM 611236), WNT1 (OMIM 164820), SP7 (OMIM
606633), SERPINF1 (OMIM 172860), SERPINH1 (OMIM
600943) (2), and most recently, P4HB (OMIM 176790) (3) and
SEC24D (OMIM 607186) (4).
Type I collagen, themajor extracellularmatrix component of
bone, is a triple helical molecule composed of two pro-1(I)
chains and one pro-2(I) chain, encoded by COL1A1 and
COL1A2, respectively. In the rough ER, folding of the three
pro- chains into a triple helix begins at their C-terminal end
and proceeds in a zipper-like fashion toward the N-propeptide
(5). To allow for the folding of procollagen chains into the triple* The work was supported by the Swiss National Foundation (SNF-Grant
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helix, modifying enzymes such as prolyl hydroxylases and sev-
eral ER chaperones are needed (6).
Among them, HSP47 encoded by SERPINH1 acts as a colla-
gen-specific chaperone (7) that preferentially binds the folded
triple helix, thus stabilizing the structure (8, 9). It is also
believed to prevent the lateral aggregation of procollagen triple
helices in the ER (10) and guard their transport from the ER to
the cis-Golgi (11, 12). In the Golgi, the pH drop releases bound
HSP47,which is recycled back to the ERby its C-terminal RDEL
sequence (13, 14).
In dachshunds, a p.L326P mutation in HSP47 was found to
cause a severe recessive form of OI characterized by marked
osteopenia, thin bones with inhomogeneous and shallow trabe-
culation in the entire foreleg, joint hyperlaxity and undermin-
eralization of the teeth (dentinogenesis imperfecta) (15). Previ-
ous clinical and histological investigations in OI dachshunds,
performed before the mutation had been identified, have
revealed bone fragility due to a paucity of cancellous and corti-
cal lamellar bone (16). In humans, a single case with a severe
form of OI due to a homozygous missense mutation (p.L78P)
rendering theHSP47 protein instable has been reported (17). In
mice, the knock-out of Hsp47 resulted in embryonic lethality
around day 11 post-coitum, suggesting a pivotal role during
development (18).
Although previous studies in humans andmice have demon-
strated the importance of HSP47 for the formation of type I
collagen, the underlying pathomechanism leading to OI is not
well understood. Therefore, we set out to biochemically char-
acterize this naturally occurring OI dog model, to further
understand the role of HSP47 in procollagen processing and
bone formation, and thereby to enhance our understanding of
the pathology of OI.
Experimental Procedures
Cell Culture—Primary fibroblast cultures were established
from skin biopsies of an affected 10-week-old dachshund (OI)
and two control dogs, a Bernese mountain dog (Contr. 1) and a
3-year-old mongrel (Contr. 2), by explant culture. Cells were
grown in standard cell culture medium composed of DMEM
(Gibco, 31966) supplemented with 10% fetal calf serum, 100
units/ml of penicillin, 100 g/ml of streptomycin, and 0.25
g/ml of amphotericin B (Gibco).
Collagen Synthesis and Secretion Analysis—For steady-state
analysis of collagen produced in vitro by cultured fibroblasts,
FIGURE 1.Mutant HSP47 is expressed as a stable protein and localizes to the ER. A and B, Western blot of HSP47 in primary cultured fibroblasts of mutant
(OI) and a control dog (Contr. 1). Themutant protein level is reduced to half of the control level. Proteasome inhibition by treatment withMG-132 (50M, 16 h)
does not influence the amount of either mutant or wild-type protein. Error bars indicate S.D. C, immunofluorescent staining of HSP47 in primary cultured
fibroblasts of mutant and control dog. The protein is similarly detectable in both mutant and control fibroblasts and co-localizes with the endoplasmic
reticulummarker GRP78. Cell nuclei stained with DAPI are shown in blue.
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the cells were seeded into 6-well culture plates (250,000 cells/
well). After 24 h, the cell culture medium was replaced by
serum-free minimum Eagle’s medium (Gibco, 41090) supple-
mented with 50 g/ml ascorbate, 50 g/ml catalase, 10 Ci of
[2,3-3H]proline, and 10 Ci of [2-3H]glycine (PerkinElmer) for
16 h. Themedium and cell layers were harvested, digested with
25 M pepsin in Hanks’ balanced salt solution (Gibco) for 2 h,
precipitatedwith ethanol, and analyzed on a 5%polyacrylamide
gel containing 0.1% SDS and 0.5 M urea. After fixation in sul-
fosalicylic acid/trichloroacetic acid, the gel was impregnated
with 2,5-diphenyloxazole (43.4 g in 200 ml of dimethyl sulfox-
ide) and subjected to fluorography.
For the pulse-chase analysis, fibroblasts were seeded into
3.5-cm tissue culture plates at 250,000 cells/dish, allowed to
settle overnight, and then incubated in cell culture medium
supplemented with 50 M ascorbate for 24 h. The cells were
pulse-labeled in minimum Eagle’s medium supplemented
with 50 M ascorbate, 30 Ci of [2,3-3H]proline, and 30 Ci
of [2-3H]glycine for 20 min. The cells were then chased for 0,
20, 40, and 80 min in minimum Eagle’s medium supple-
mented with 2 mM unlabeled proline and 2 mM unlabeled
glycine. At the end of each chase, the medium and cell layers
were harvested separately, digested with pepsin, and subjected to
fluorography. The quantification was done using the Gel Logic
6000 PRO Imager (Carestream) and the Carestream Molecular
ImagingSoftware.Theexperimentwasperformed twicewith sim-
ilar results.
Western Blot Analysis of HSP47, phospho-eIF2, and
GRP78—Fibroblasts were seeded into T75 flasks and grown to
confluency.Whole cell extracts were prepared by lysing cells in
Nonidet P-40 buffer (50 mM Tris/HCl, pH 8, 125 mM NaCl, 1%
NP-40, 1 mM EDTA, 1 mM PMSF) and protease inhibitor cock-
tail (Roche Diagnostics) for 45 min on ice. For the induction of
ER stress or proteasome inhibition, cells were treated with 0.5
M thapsigargin (Sigma) for 4 h or 50 M MG-132 (Enzo Life
Sciences) for 16 h, respectively, prior to harvesting. 50 g of
protein were analyzed on a 10% SDS gel, followed by Western
blot. The following antibodies were used: mouse anti-HSP47
(ADI-SPA-470-D; Enzo Life Sciences) at 1:1000; rabbit anti-
GRP78 (Abcam) at 1:1000; phospho-eIF2-(Ser-51) (9721; Cell
Signaling Technology) at 1:1000; mouse anti-actin (A1978;
Sigma) at 1:3000; goat anti-mouse HRP (sc-2302; Santa Cruz
Biotechnology) at 1:3000; and goat anti-rabbit HRP (sc-2301;
Santa Cruz Biotechnology) at 1:3000. The blots were developed
using the ECL system (GE Healthcare Life Sciences) and quanti-
fied using the Gel Logic 6000 PRO (Carestream) and the Care-
stream Molecular Imaging Software. For the calculation of
standard deviations, three independent experiments were
combined.
Immunofluorescent Staining—Fibroblasts were split from a
confluent T75 flask and seeded onto glass coverslips in
12-well tissue culture plates. After 24 h, the cells were fixed
either in ice-cold methanol for 5 min (for anti-HSP47) or in
4% paraformaldehyde for 10 min followed by incubation in
ice-cold methanol for 1 min (for anti-Col I). Cells were
washed three times in PBS (10 mMNa2HPO4, 2 mM KH2PO4,
137 mM NaCl, 2.7 mM KCl) and incubated in blocking buffer
(1% BSA, 10% FCS, 0.3 M glycine, 0.1% Tween 20 in PBS) for
1 h at room temperature. The cells were then incubated with
the respective primary antibodies diluted in blocking buffer
for 1.5 h at room temperature, washed three times in PBS,
and incubated with the secondary antibodies diluted in block-
ing buffer for 1 h at room temperature. After washing three times
in PBS, the coverslips weremounted onto glass slides using Slow-
Fade Gold antifade mountant (S36939, Molecular Probes) con-
tainingDAPI for nuclear staining. Imageswere taken on a fluores-
cence microscope (Leica HC DMIL equipped with a Leica
DFC420 digital camera).
Primary antibodies were: mouse anti-HSP47 (M16.10A1,
ADI-SPA-470) from Enzo Life Sciences (1:100); rabbit anti-
GRP78 (ab32618) from Abcam (1:100); mouse anti-collagen I
(ab6308) from Abcam (1:100); and rabbit anti-GM130
(ab52649) from Abcam (1:100). Secondary antibodies were:
goat anti-rabbit Alexa Fluor 568 (ab175471) from Abcam
(1:500) and goat anti-mouse Alexa Fluor 488 (A11017) from
Molecular Probes (1:500).
ElectronMicroscopy of Cultured Primary Fibroblasts—Fibro-
blasts were seeded into T75 flasks and grown to confluency
(two flasks per sample). Then, the cells were washed twice in 8
ml of ice-coldHanks’ balanced salt solution (Gibco) and fixed in
3 ml of fixation solution (3% glutaraldehyde (Sigma) in 0.1 M
FIGURE 2.Overmodification of type I collagen and intracellular retention
of types I, III, andV collagen inHSP47mutant fibroblasts.A and B, steady-
state analysis of pepsinized (A) and unpepsinized (B) procollagen by SDS-
PAGE in primary cultured fibroblasts of HSP47 mutant (OI) and a control dog
(Contr. 1). Thepro1(I) andpro2(I) (inpanel B) aswell as the1(I) and2(I) (in
panel A) bands from mutant fibroblasts show decreased electrophoretic
mobilitywhen comparedwith the control, indicating overmodification of the
triple helical and possibly the telopeptide region. Pro1(I) and pro2(I) are
retained in the cell layer. Also, type III and type V collagen are retained in the
cell layer as evident in the pepsinized collagen analysis (A).
The Collagen I Chaperone HSP47 in Osteogenesis Imperfecta
JULY 17, 2015•VOLUME 290•NUMBER 29 JOURNAL OF BIOLOGICAL CHEMISTRY 17681
 at U
ZH
 H
auptbibliothek / Zentralbibliothek Zuerich on A
ugust 26, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
cacodylate buffer, pH 7.4) for 16 h at 4 °C. The fixation solution
was removed, and the cells were harvested using a rubber
policeman in 1 ml of 0.1 M cacodylate buffer into 2-ml Eppen-
dorf tubes and centrifuged at 13,000 rpm for 1 min. The super-
natantwas discarded, and the cell pellet waswashed three times
in 0.1 M cacodylate buffer, post-fixed for 1 h in 1% osmium
tetroxide, dehydrated by a graded series of ethanol, and embed-
ded in glycidether 100 (Carl Roth) (formerly Epon 812). Semi-
thin and 70–80-nm ultrathin sections were cut with a Reichert
Ultracut E ultramicrotome, counterstained with uranyl acetate
and lead citrate, and examined with a Zeiss EM900, equipped
with a CCD camera from Troendle Restlichtverstaerker-Sys-
teme (TRS).
Tissue Preparation for Collagen Analysis—Stored frozen tis-
sues from an affected dachshund pup (10 weeks old) and two
control dogs (9-year-old large breed dog and 14-year-old small
breed dog) were used for analysis. Mid-shaft cortical bone and
skin were scraped clean and defatted with chloroform/metha-
nol (3:1 v/v); bone was demineralized in 0.1 MHCl, and all steps
were carried out at 4 °C. Collagen was solubilized from each
tissue by heat denaturation in SDS-PAGE sample buffer at
90 °C without DTT. Demineralized bone was also extracted
with pepsin in 3% acetic acid at 4 °C and then precipitated by
adding NaCl to 0.8 M.
SDS-PAGE of Bone and Skin Collagen Extracts—Themethod
of Laemmli (19) was used with 6% gels for extracts of tissue
collagen.
Cross-link Analysis—Bone was hydrolyzed in 6 N HCl, dried,
dissolved in 1% (v/v) n-heptafluorobutyric acid, and analyzed
by C18 reverse-phase HPLC as described (20).
FIGURE 3.Delayed secretion of type I and typeV collagen.A, pulse-chase analysis of pepsinized collagen in primary fibroblasts showing a delay in secretion
of type I and type V collagen from the cell layer (C) into the medium (M) in the OI dog (OI) when compared with the control dog (Contr. 1). B, quantification of
the pulse-chase experiment for type I collagen.
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Mass Spectrometry of Collagenase-digested Bone—Deminer-
alized bonewas digestedwith bacterial collagenase as described
(21), and collagenase-generated peptides were separated by
reverse-phase HPLC (C8, Brownlee Aquapore RP-300, 4.6
mm 25 cm) with a linear gradient of acetonitrile:1-propanol
(3:1 v/v) in aqueous 0.1% (v/v) trifluoroacetic acid (22). Electro-
spray MS was performed on individual fractions using an LTQ
XL ion trap mass spectrometer (Thermo Scientific) equipped
with in-line liquid chromatography using a C4 5-m capillary
column (300 m  150 mm; Higgins Analytical RS-15M3-
W045) eluted at 4.5 l/min. The LC mobile phase consisted of
buffer A (0.1% formic acid in Milli-Q water) and buffer B (0.1%
formic acid in 3:1 acetonitrile:propanol-1 (v/v)). The LC sample
stream was introduced into the mass spectrometer by electro-
spray ionization with a spray voltage of 4 kV. The Proteome
Discoverer search software (Thermo Scientific) was used for
peptide identification using the National Center for Biotech-
nology Information (NCBI) protein database. Proline and lysine
modifications were examined manually by scrolling or averag-
ing the full scan over several minutes so that all of the post-
translational variations of a given peptide appeared together in
the full scan.
Results
ProteinStabilityandNormalLocalizationofHSP47(p.L326P) in
Dog Primary Fibroblasts—To test whether the L326P mutation
has any effect on the expression and stability of the HSP47
protein, we performedWestern blot analysis and immunofluo-
rescent staining in cultured fibroblasts. In the Western blot
analysis, the amount of HSP47 in the mutant fibroblasts was
reduced by half when compared with the control (Fig. 1, A and
B). Upon proteasome inhibition using MG-132, the amount of
protein was not increased further. The immunofluorescent
staining ofHSP47 showed that the protein was similarly detect-
able in control as well as in HSP47 mutant fibroblasts (Fig. 1C).
The staining patternwas similar inmutant and control cells and
co-localized with the ER marker GRP78.
HSP47 Is Required for Efficient Folding and Secretion of Type
I Procollagen—Wenext aimed to investigate whether themuta-
tion in HSP47 impairs its ability to act as a chaperone, thereby
affecting type I procollagen folding. To this end, biochemical
analyses of procollagen I were performed. The steady-state
analysis of pepsinized procollagen separated by SDS-PAGE
showed that in both themediumand the cell layers, the bands of
the collagen I  chains had decreased electrophoretic mobility
in mutant when compared with control fibroblasts, and also
had a broader appearance in the cell layer (Fig. 2A). Further-
more, an increased amount of procollagen I, III, and V when
compared with the control was detected in the cell layer (Fig.
2A). Similarly, SDS-PAGE of unpepsinized procollagen showed
an increased amount of the pro-1(I) and pro-2(I) chains in
the cell layer and decreased electrophoretic mobility of fully
processed 1(I) and 2(I) chains in the medium layer (Fig. 2B).
Additionally, in the medium layer, the amount of fully pro-
cessed 1(I) and 2(I) chains was decreased in mutant dog
fibroblasts when compared with control fibroblasts (Fig. 2B).
These findings suggest that procollagen I is overmodified in the
helical part and possibly in the telopeptide region and is less
efficiently processed in the extracellular space. The increased
amounts of collagen I, III, and V in the cell layer might indicate
intracellular retention or decreased secretion of fibrillar colla-
gens in HSP47 mutant cells.
We further investigated the secretion of collagen from
mutant dog fibroblasts by pulse-chase analysis. Inmutant fibro-
blasts, the secretion of type I and type V collagen from the
medium into the cell layer was slightly decreased when com-
pared with the control fibroblasts (Fig. 3, A and B). This was
FIGURE4.Type I collagenaccumulates inHSP47mutant fibroblasts.A and
B, co-immunofluorescent staining of primary skin fibroblasts for Col I (green)
and the ER marker GRP78 (A) or the Golgi marker GM130 (B), both shown in
red. The two control cell lines (Contr. 1 and 2) show weak collagen I staining
overlappingwith theGolgimarker. In HSP47mutant fibroblasts (OI), collagen
I staining ismuch stronger andmore spreadout overlappingwithboth the ER
marker and the Golgi marker.
FIGURE 5. Dilation of endoplasmic reticulum cisternae in HSP47
mutant fibroblasts. Transmission electron microscopy of primary fibro-
blasts from HSP47 mutant dog (OI) shows increased abundance of
enlarged endoplasmic reticulum cisternae (red arrows) when compared
with control dog fibroblasts.
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most evident in the 20-min chase for type I collagen and in the
80-min chase for type V collagen.
Finally, co-immunofluorescent staining was performed
using antibodies against the helical part of type I collagen, the
ER chaperone GRP78, and the Golgi marker GM130 (Fig. 4, A
and B). In agreement with the findings above, mutant cells
showed a strong staining for type I collagen (Col I) and only
faint staining in two different control cell lines (Contr. 1 and
Contr. 2). Furthermore, the staining pattern in control cells
overlapped with the Golgi marker (Fig. 4B), but was more
spread out in the OI cells overlapping with both the Golgi and
the ER marker. Taken together, these observations point
toward delayed folding and intracellular retention of procolla-
gen I and raise the question of a possible induction of an ER
stress response.
Dilation of ER Cisternae and Activation of the ER Stress
Response in HSP47 Mutant Fibroblasts—To investigate
whether the intracellular retention of collagen might cause
ultrastructural alterations, transmission electron microscopy
was performed on cultured fibroblasts from the HSP47 mutant
and a control dog. Dilation of the endoplasmic reticulum in the
mutant fibroblasts was more pronounced than in the control
cells (Fig. 5). To test for the activation of an ER stress response,
GRP78 and phospho-eIF2, which are induced upon accumu-
lation of unfolded proteins, were analyzed byWestern blot (Fig.
6,A–D). InHSP47mutant cells, the amount of GRP78 (Fig. 6,A
and B) as well as phospho-eIF2 (Fig. 6,C andD) was increased
when compared with control cells. Exposure to the ER stress
inducer thapsigargin led to an increase in control cells, whereas
it remained at a high level in the HSP47mutant cells. Induction
of autophagy was not observed inWestern blot analysis testing
for LC3B lipidation (data nor shown).
Overhydroxylation and Altered Cross-linking of Bone
Collagen—To investigate whether the overmodification of col-
lagen observed in cultured skin fibroblasts was evident in
HSP47 mutant dog tissue, we directly analyzed collagens
extracted from bone and skin (Fig. 7). Chain mobilities were
clearly slower from mutant when compared with control dog
FIGURE 6. ER stress markers are up-regulated in HSP47 mutant fibroblasts. A–D, Western blot analysis (A and C) and quantification (B and D) of three
independent experiments of GRP78 and phospho-eIF2 (P-eIF2). The amount of both ER stress marker proteins is increased in untreated (-) HSP47 mutant
fibroblasts (OI) when comparedwith the level in control cells (Contr. 2). Induction of ER stress by treating cells with thapsigargin (Thap.) leads to an increase in
control cells, whereas remaining on a high level in HSP47 mutant cells. GRP78 is detected as a double band, probably due to post-translational modification.
Error bars indicate S.D.
FIGURE 7.Decreased electrophoretic mobility of type I collagen chains
from HSP47 mutant bone and skin. SDS-PAGE (6%) of type I collagen
extracted by heat denaturation or pepsin from HSP47 mutant (OI) bone
and heat denaturation of skin shows decreased electrophoretic mobility
of the  and  chains when compared with the 9-year-old control dog
(Control).
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tissues. Individual collagen chains were excised from the SDS-
PAGE gel and subjected to trypsin digestion, and lysine hydrox-
ylation was assessed by tandem mass spectrometry in targeted
peptides from bone collagen of an HSP47 mutant dog and two
control dogs. The tandemmass spectrometry analysis revealed
an increase in helix and telopeptide lysinemodification (Fig. 8).
Residue Lys-87 was overglycosylated as glucosyl-galactosyl-hy-
droxylysine (glcgalHyl) in the mutant when compared with
galactosyl-hydroxylysine (galHyl) in the controls, and Lys-930
was essentially all Hyl in the mutant but mostly Lys in control
bone. From the same trypsin digests, 3-hydroxylation of Pro-
986 was found to be essentially complete and indistinguishable
from that in controls.
Further analysis of pyridinoline cross-links in total hydroly-
sates of bone collagen showed an increase in the total pyridino-
line content (HPLP moles per mole of collagen) and in the
ratio of hydroxylysyl pyridinoline (HP) to lysyl pyridinoline
(LP) in themutant bone when compared with bone of two con-
trol dogs (Table 1). Furthermore, pyrrole cross-links were not
detectable on reaction of decalcified mutant bone with
FIGURE 8. Overmodification of lysine residues at cross-linking sites in HSP47 mutant bone collagen revealed by tandem mass spectrometry. A,
peptides from the four molecular sites of cross-linking in collagen type I prepared by bacterial collagenase digestion of decalcified bone were identified by
LC-MS. Their post-translational profiles are compared between HSP47mutant and control (9-year-old dog) bone. N-telo, N-telopeptide; C-telo, C-telopeptide.
B and C, spectra from the two helical sites (Lys-87 and Lys-930) (B) and two telopeptide sites (C) show that Lys-87 ismostly glcgalHyl, Lys-930 ismostly Hyl, and
both telopeptides are essentially all Hyl frommutant bone, whereas from control bone Lys-87 ismostly galHyl, Lys-930 is highly underhydroxylated, and both
telopeptides are about 50% hydroxylated.
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Ehrlich’s reagent but strongly reactive in control dog and
human bone (data not shown).
Discussion
SERPINH1, encoding HSP47, is a chaperone essential for
efficient folding of collagen triple helices in the ER, thereby
possibly preventing their aggregation in the ER and facilitating
their transport into the Golgi (7, 9–12). Its pivotal role in bone
formation became evident when it was shown to cause a reces-
sive form of OI in the dachshund (15) and then in humans (17).
However, the disease mechanism is not well understood. Here,
we provide a detailed biochemical analysis, showing that the
HSP47 mutation in the dog is characterized by overmodifica-
tion and intracellular retention of procollagen type I, dilation of
ER cisternae, andup-regulation of the ER stressmarkersGRP78
and phospho-eIF2 in vitro as well as by aberrant bone collagen
cross-linking in vivo. Furthermore, we compare our findings
with those recently made in the human OI case (17) and in
HSP47 knock-out mice (18, 23) (summarized in Table 2) and
discuss their implications for procollagen I processing and bone
formation in the context of understanding the pathomecha-
nism of OI.
In the reported humanOI case, themutant HSP47was insta-
ble and only detectable upon proteasome inhibition (17), pro-
viding an explanation for its loss of function. In our study, we
show that the mutant HSP47 in the dog was clearly detectable
by immunofluorescent staining and by Western blot, although
the latter analysis showed a decrease by half (Fig. 1). However, it
seems unlikely that this decrease in the amount of HSP47
causes the OI pathology because mice heterozygous for the
knock-out were phenotypically normal and procollagen I pro-
cessing and protease sensitivity were similar to wild type
despite a marked decrease in HSP47 (18). More likely, the
HSP47 mutation in the dog leads to structural alterations and
some loss of function. For example, aggregation or polymeriza-
tion ofmutant HSP47 in the ER, as has been observed formuta-
tions in other members of the serpin family in so-called serpi-
nopathies (24), could affect its availability as a chaperone, and
provide an explanation for its stability.
It is presumed that mutations in genes coding for collagen
chains or their chaperones can delay procollagen triple helix
formation, leading to prolonged exposure of the nascent chains
to hydroxyl- and glycosyltransferases in the ER. Thus, slower
migration of the 1(I), 2(I), and  chains of collagen type I is
often detected by SDS-PAGE analysis in cultured fibroblasts
fromOI patientswithmutations inCOL1A1,COL1A2,CRTAP,
LEPRE1, or PPIB (25–28). In the humanHSP47OI case, migra-
tion of cell culture collagenwas reported to be normal. In theOI
dog, we observed slower migration of type I collagen chains
from cell lysates, from culture medium, and from bone matrix
extracts (Figs. 2 and 7). This points toward at least a partial loss
of the HSP47 chaperone function leading to delayed folding or
to local micro-unfolding of the collagen triple helix, thus allow-
ing for increased post-translational modification of collagen
(see proposedmechanism, Fig. 9). The findings further indicate
that incorrectly modified collagen is secreted into the extracel-
lular space in vitro, which may contribute to the OI pathology.
The reason for the different findings between the human and
the dog cases remains unclear. They may have been due to the
different mutations (p.L326P versus p.L78P). Alternatively,
post-translational overmodification in the human case may
have been less obvious in cell culture, and because no bone was
available for analysis, any effect on collagen cross-linking is
unknown (17).
The observation of overmodified collagen in vitro was sup-
ported by tandemmass spectrometry of bone collagen from an
affected dog showingmarkedly increasedmodification levels of
lysine at cross-linking sites in the helix and both telopeptides.
Other non-cross-linking lysines in the helix also showed
increased hydroxylation (Fig. 8 and data not shown). Direct
analysis of mature cross-links showed more than double the
content of total pyridinolines (HPLP) as well as an increased
HP/LP ratio (Table 1) consistent with the tandem mass spec-
trometry results on their linear precursor sequences (Fig. 8). In
normal bone collagen, the predominant mature cross-links are
pyrroles and pyridinolines, which are usually present in equal
molar amounts (21, 29). In essence, two telopeptide lysine res-
idues and one helix lysine contribute to each cross-link, so the
extent of hydroxylation of these lysines determines the cross-
link chemistry. Two telopeptide hydroxylysines produce pyr-
idinolines, whereas pyrrole cross-links form when one of the
two telopeptide lysines is unhydroxylated (30). Thus, the shift
from pyrrole to pyridinoline cross-links evident in mutant dog
bone is consistent with the apparent complete telopeptide
lysine hydroxylation (Fig. 8). Similarly, the increase in helix
lysine hydroxylation in bone of the HSP47 mutant dog is
responsible for the increased HP/LP ratio.
One limitation of the tissue studies, however, was the lack of
age-matched normal dog tissues for direct comparison. It is
possible therefore that some of the modification increase is
age-related.
TABLE 1
Cross-link analysis of dog bone
The mature trivalent cross-links LP and HP from dog bone were quantified by
HPLC. In the OI dog, the HP content is increased, whereas the LP content is not
altered when compared with controls. Accordingly, the total pyridinoline content
(HPLP) as well as the HP/LP ratio are increased.
Dog bone sample type Mutation
Residue/collagen
HP/LPHP LP HPLP
Control 14 year 0.11 0.03 0.14 3.7
Control 9 year 0.13 0.05 0.18 2.6
OI dog 10 week SERPINH1 p.L326P 0.36 0.05 0.41 7.2
TABLE 2
Summary and comparison of biochemical data on HSP47 defects in
mouse, human, and dog
ND not determined.
Consequences of HSP47
defect
Mouse KO
(18, 23)
Human
(L78P) (17)
Dog
(L326P)
Phenotype Embryonic lethal OI OI (15)
HSP47 protein instability (Not expressed) Yes No
Col I overmodification ND No Yes
Delayed Col I secretion Yes Yes Yes
Inefficient Col I processing Yes ND Yes
Abnormal 3-hydroxylation of
Pro-986
ND No No
Accumulation of Col I in ER
or Golgi
ER Golgi ER
ER dilation Yes ND Yes
Bone cross-linking alterations ND ND Yes
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It is notable that variations in relative contents of pyrrole and
pyridinoline cross-links have been associated with differences
in human vertebral trabecular bonemorphologies (31). In bone
ofOI dachshunds, the development of secondary spongiosawas
noted to be defective (16). This suggests that the overhydroxy-
lated type I collagen in the extracellular matrix might disturb
the bone-specific cross-linking of type I collagen and negatively
influence trabecular bone formation, thereby contributing to
the OI pathology. Abnormal collagen cross-linking is charac-
teristic of several subtypes of OI including Bruck syndrome, in
which bone collagen lacks pyridinolines, and subtypes of the
Ehlers-Danlos syndrome; in both of these conditions, the diag-
nosis can be confirmed by analysis of pyridinoline cross-links in
urine (28, 30, 32–35).
The accumulation or retention of collagen in HSP47 mutant
cells was consistently observed from mouse (23), human (17)
FIGURE 9.ProposedpathomechanismofOI inducedby theHSP47mutation in the dog. Symbols used are: green spheres, HSP47; yellow triangles, hydroxy-
lysyl residues; gray circles, glucosyl-galactosyl residues. Decreased binding of HSP47 to the collagen triple helix delays collagen folding overall and allows for
localmicro-unfoldingof the triple helix after its formation, thus leading to an increased exposure to lysyl-hydroxylases andglucosyl-galactosyltransferases and
to increased post-translationalmodification of the triple helix and the telopeptides involving the cross linking sites (87 and 930, N-telopeptide and C-telopep-
tide). A portion of overmodified collagen is transported from the rough ER (rER) into the Golgi, and afterward into the extracellular space, whereas a portion of
it accumulates in the rough ER, inducing ER stress. The secretion of overmodified collagen molecules to the extracellular space leads to abnormal collagen
cross-linking in bone, i.e. an increase of HP and a decrease of pyrrole cross-links (gray vertical bar, pyrrole; dark gray vertical bar, HP; light gray vertical bar, LP).
Both induction of ER stress and altered collagen cross-linking may contribute to the pathomechanism of OI.
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and, in the present study, dog using pulse-chase (Fig. 3) and
immunofluorescent staining methods (Fig. 4) as well as steady-
state analysis of collagen and procollagen type I (Fig. 2). There is
some discrepancy in the site of observed intracellular collagen
accumulation. In the human case, Christiansen et al. (17)
showed that type I procollagen was diminished in the ER and
accumulated in the Golgi, whereas in the mouse HSP47 knock-
out cells, procollagen I accumulated in the ER (23). Interest-
ingly, immunofluorescent staining in dog fibroblasts also dis-
played increased staining of procollagen I in the ER. Although
this could reflect distinct pathomechanisms leading toOI in the
human and dog cases, an alternative explanation is the use of
different antibodies. In the mouse and in the present study, an
antibody directed against the triple helix of collagen was used,
whereas in the human case, the antibody detected the N-pro-
peptide of the pro-1(I) chain. Retention of procollagen type I
in the ER in the OI dog is supported by the present findings of
an activated ER stress response (Fig. 6) and enlarged ER cister-
nae seen on transmission electron microscopy (Fig. 5) in cul-
tured fibroblasts. Indeed, similar observations have been made
by transmission electronmicroscopy in fibroblasts fromHSP47
knock-out mice (23) and in osteoblasts in bone from an OI
dachshund (16). Thus, our findings suggest that activation of
the ER stress response by misfolded and retained procollagen
could play a role in the pathomechanism of OI in the dachs-
hund. Mutant HSP47 aggregating or polymerizing in the ER, as
discussed above,might further contribute to ER stress. Involve-
ment of ER stress has already been discussed as being impli-
cated in OI, and increased apoptosis, impaired differentiation,
and decreased activity or survival of osteoblasts have been pro-
posed as possible pathomechanisms (36–39).
Taken together, our findings suggest an impairment of the
HSP47 chaperone function in the ER, leading to overhydroxyl-
ation and partial intracellular retention of procollagen I. Both
consequences, ER stress and aberrant bone collagen cross-link-
ing, have the potential to play a causative role in the OI pathol-
ogy, and further studies are required to determine their individ-
ual significance. Finally, with regard to diagnostics of OI caused
by a mutation in HSP47, overmodification of collagen I may be
evident in fibroblast cultures on SDS-PAGE analysis, and an
increasedHP/LP ratio of bone collagen is potentially detectable
by urinary pyridinoline analysis.
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